Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
Condition: Metastatic Castration-Resistant Prostate Cancer Interventions: Drug: Lu-PSMA; Drug: Enzalutamide Sponsors: Australian and New Zealand Urogenital and Prostate Cancer Trials Group; National Health and Medical Research Council, Clinical Trials Centre; Prostate Cancer Research Alliance; Endocyte; Astellas Pharma Inc; Australian Nuclear Science and Technology Organisation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Australia Health | Cancer | Cancer & Oncology | Clinical Trials | New Zealand Health | Prostate Cancer | Research | Science